Goldenwell Biotech, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GWLL research report →
Price Chart
About the company
Goldenwell Biotech, Inc. , focuses on nutraceutical and dietary supplements business in the United States. It is developing JI MAI, a bovine cardiac vascular active peptide; Double Proline AG, a 3D active collagen peptide drinkable cosmetic; Cartilage Peptide, a Type II collagen peptide; and Sugar Master, a dietary supplement.
- CEO
- Shuang Liu
- IPO
- 2022
- Employees
- 3
- HQ
- Solon, OH, US
Get TickerSpark's AI analysis on GWLL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $68.28M
- P/E
- -255.44
- PEG
- 1.45
- P/S
- 2943.75
- P/B
- -198.65
- EV/EBITDA
- -270.21
- Div Yield
- 0.00%
- Gross Margin
- 107.83%
- Op Margin
- -409.10%
- Net Margin
- -1130.45%
- ROE
- 89.25%
- ROIC
- 133.61%
Latest fiscal year · YoY change
- Revenue
- $55-60.4%
- Gross Profit
- $12-81.3%
- Op Income
- $-113,326
- Net Income
- $-296,471-125.5%
- EPS
- $-0.00-130.8%
- OCF Growth
- +81.6%
- FCF Growth
- +81.6%
- 52W High
- $10.00
- 52W Low
- $0.20
- 50D MA
- $0.73
- 200D MA
- $0.98
- Beta
- 4.81
- RSI (14)
- 19
- Avg Volume
- 39
No earnings-call transcripts are available for GWLL yet.
- Free Float
- 36.4%
- Shares Outstanding
- 99.00M
- Float Shares
- 36.00M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 30, 21 | Yang Li | other | 0 |
| Apr 30, 21 | Liu Shuang | other | 0 |
| Apr 30, 21 | Xie Hua | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our GWLL coverage
Recent articles, reports, and earnings notes.
No research on GWLL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GWLL report →